JFNIX Mutual Fund

NAV$89.02
Showing 10 of 109 holdings(as of Dec 31, 2025)Top 10 Weight: 38.81%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company9.65%481,268$517.21M-Health CarePharmaceuticals
2JNJJOHNSON AND JOHNSON5.58%1,444,532$298.95M-Health CarePharmaceuticals
3AZN:LNAstrazeneca Plc Adr4.26%1,240,485$228.45MProProPro
4UNHUnitedhealth Group, Inc.3.43%557,669$184.09MProProPro
5ABBVAbbvie Inc Health Care3.39%794,492$181.53MProProPro
6ABTAbbott Laboratories2.64%1,130,599$141.65MProProPro
7ARGXArgenx NV ADR2.63%167,389$140.77MProProPro
8NVS:SMNovartis Ag, Adr2.50%971,981$134.01MProProPro
9PRAXPraxis Precision Medicines Inc Common Stock Usd.00012.39%433,759$127.85MProProPro
10BSXBoston Sci Com Usd0.012.34%1,318,073$125.68MProProPro
See the other 99 holdings of JFNIX
Every position with sector, industry and share changes, as reported Dec 31, 2025.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesImmunologyLife Sciences ToolsBiotechnology ToolsOncologyCardiologyDigital Health

JFNIX Mutual Fund Top Holdings

JFNIX holdings top 10 positions. The top 10 holdings account for 38.8% of the fund, led by Eli Lilly And Company at 9.7%, JOHNSON AND JOHNSON at 5.6%, Astrazeneca Plc Adr at 4.3%.

JFNIX portfolio concentration is moderate, with the top 10 representing 38.8% of total assets. The largest sector exposure is Health Care at 75.2%.

JFNIX sector allocation provides a detailed breakdown. JFNIX overlap tool shows how holdings compare to other funds in your portfolio.